John G Ullman & Associates Inc. cut its position in Thermo Fisher Scientific Inc. (NYSE:TMO) by 1.2% during the second quarter, Holdings Channel reports. The firm owned 28,492 shares of the company’s stock after selling 334 shares during the period. John G Ullman & Associates Inc.’s holdings in Thermo Fisher Scientific were worth $4,210,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in TMO. Nomura Asset Management Co. Ltd. increased its position in shares of Thermo Fisher Scientific by 0.7% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 45,772 shares of the company’s stock valued at $6,493,000 after buying an additional 330 shares in the last quarter. CENTRAL TRUST Co purchased a new position in shares of Thermo Fisher Scientific during the first quarter valued at about $3,121,000. Fjarde AP Fonden Fourth Swedish National Pension Fund increased its position in shares of Thermo Fisher Scientific by 15.4% in the first quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 91,144 shares of the company’s stock valued at $12,905,000 after buying an additional 12,150 shares in the last quarter. Webster Bank N. A. increased its position in shares of Thermo Fisher Scientific by 3.2% in the first quarter. Webster Bank N. A. now owns 30,387 shares of the company’s stock valued at $4,302,000 after buying an additional 934 shares in the last quarter. Finally, CHURCHILL MANAGEMENT Corp purchased a new position in shares of Thermo Fisher Scientific during the first quarter valued at about $1,314,000. Institutional investors and hedge funds own 87.47% of the company’s stock.

Thermo Fisher Scientific Inc. (NYSE:TMO) traded up 0.03% during trading on Friday, reaching $150.05. 1,985,523 shares of the company traded hands. The company has a market capitalization of $59.16 billion, a P/E ratio of 30.02 and a beta of 1.00. The firm has a 50-day moving average price of $153.94 and a 200-day moving average price of $148.48. Thermo Fisher Scientific Inc. has a 52 week low of $117.10 and a 52 week high of $160.68.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings data on Thursday, July 28th. The company reported $2.03 EPS for the quarter, beating the consensus estimate of $2.01 by $0.02. Thermo Fisher Scientific had a net margin of 11.35% and a return on equity of 14.70%. The business earned $4.54 billion during the quarter, compared to analysts’ expectations of $4.50 billion. During the same period in the previous year, the business posted $1.84 EPS. The business’s quarterly revenue was up 6.2% compared to the same quarter last year. Analysts forecast that Thermo Fisher Scientific Inc. will post $8.15 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, October 17th. Shareholders of record on Thursday, September 15th will be paid a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a yield of 0.40%. The ex-dividend date is Tuesday, September 13th. Thermo Fisher Scientific’s payout ratio is 12.02%.

TMO has been the topic of several analyst reports. Zacks Investment Research upgraded shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $175.00 target price on the stock in a research note on Wednesday, July 20th. BTIG Research upgraded shares of Thermo Fisher Scientific from a “neutral” rating to a “buy” rating and set a $180.00 target price on the stock in a research note on Friday, July 22nd. Mizuho set a $175.00 target price on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a research note on Thursday, July 28th. Cleveland Research downgraded shares of Thermo Fisher Scientific from a “buy” rating to a “neutral” rating in a research note on Friday, September 9th. Finally, Jefferies Group reiterated a “hold” rating on shares of Thermo Fisher Scientific in a research note on Thursday, August 4th. Three research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $159.66.

In other Thermo Fisher Scientific news, Director C Martin Harris sold 390 shares of Thermo Fisher Scientific stock in a transaction that occurred on Friday, August 5th. The shares were sold at an average price of $157.33, for a total transaction of $61,358.70. Following the completion of the sale, the director now directly owns 4,648 shares in the company, valued at approximately $731,269.84. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Marc N. Casper sold 20,000 shares of Thermo Fisher Scientific stock in a transaction that occurred on Tuesday, July 5th. The shares were sold at an average price of $147.69, for a total transaction of $2,953,800.00. Following the sale, the chief executive officer now owns 340,998 shares of the company’s stock, valued at $50,361,994.62. The disclosure for this sale can be found here. Company insiders own 0.52% of the company’s stock.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

5 Day Chart for NYSE:TMO

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Receive News & Ratings for Thermo Fisher Scientific Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.